Diadexus, Inc. Share Price

DDXSQ

US25245P2056

Pharmaceuticals

Delayed OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

17/21/17	Diadexus, Inc. Went Out of Business	CI
08/18/08	Motion for Asset Sale Approved for Diadexus, Inc.	CI

Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.

Employees

Sector

Pharmaceuticals

More about the company

Stock Market
Stocks
DDXSQ Stock

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	49.2T 44.24T 41.28T 37.41T 70.24T 46.82L 70.68T 5L 2L 24.3L 2L 2L 78.16L	P/E 2014	-3.26x	P/E 2015	-1.14x
Enterprise Value	52.9L 47.56L 44.39L 40.23L 75.53L 50Cr 76L 5.33Cr 2.08Cr 26Cr 1.99Cr 1.94Cr 84Cr	EV / Sales 2014	1.05x	EV / Sales 2015	0.77x
Free-Float	100%	Yield 2014 *	-	Yield 2015	-

17/21/17	Diadexus, Inc. Went Out of Business	CI
08/18/08	Motion for Asset Sale Approved for Diadexus, Inc.	CI
09/18/09	Motion for Asset Sale Filed by Diadexus, Inc.	CI
01/16/01	Diazyme Laboratories, Inc. completed the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
29/16/29	Motion for Asset Sale Approved for Diadexus, Inc.	CI
29/16/29	General Atomics Corp. entered into purchase agreement to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $4.8 million.	CI
20/16/20	Cleveland HeartLab, Inc. cancelled the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
07/16/07	Motion for Asset Sale Filed by Diadexus, Inc.	CI
07/16/07	Cleveland HeartLab, Inc. agreed to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $7 million.	CI
13/16/13	Diadexus, Inc. Filed for Bankruptcy	CI
10/16/10	Diadexus, Inc. Announces Resignation of Leone Patterson as Chief Financial Office	CI
23/16/23	Diadexus, Sonic Healthcare USA Sign National Agreement for PLAC Activity Test	CI
30/16/30	Diadexus, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2016	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DIADEXUS, INC.	-.--%	-.--%	-	-	410
ELI LILLY AND COMPANY	+3.66%	+1.92%	+49.15%	+96.48%	1,04000Cr
JOHNSON & JOHNSON	+1.99%	-1.93%	+32.80%	+60.89%	60TCr
ABBVIE INC.	+3.32%	+4.37%	+23.61%	+92.37%	48TCr
MERCK & CO., INC.	+2.25%	+3.11%	+73.83%	+41.38%	35TCr
ROCHE HOLDING AG	+3.09%	+3.03%	+29.59%	+47.09%	35TCr
NOVARTIS AG	+2.82%	+2.20%	+17.90%	+40.67%	27TCr
ASTRAZENECA PLC	+3.40%	+0.99%	-3.44%	+12.10%	24TCr
AMGEN INC.	+2.10%	+3.07%	+44.89%	+48.41%	22TCr
GILEAD SCIENCES, INC.	+2.51%	+4.47%	+29.49%	+93.71%	18TCr
Average	+2.49%	+2.14%	+33.09%	+59.23%	37.43TCr
Weighted average by Cap.	+2.91%	+2.31%	+36.80%	+67.96%

	2014	2015
Net sales	2.61Cr 2.35Cr 2.19Cr 1.99Cr 3.73Cr 248.49Cr 3.75Cr 26Cr 10Cr 128.97Cr 9.8Cr 9.59Cr 414.8Cr	1.79Cr 1.61Cr 1.5Cr 1.36Cr 2.55Cr 170.19Cr 2.57Cr 18Cr 7.03Cr 88Cr 6.71Cr 6.57Cr 284.09Cr
Net income	-84.67L -76.13L -71.04L -64.39L -1.21Cr -81Cr -1.22Cr -8.53Cr -3.33Cr -42Cr -3.18Cr -3.11Cr -134.5Cr	-71.66L -64.43L -60.13L -54.49L -1.02Cr -68Cr -1.03Cr -7.22Cr -2.82Cr -35Cr -2.69Cr -2.63Cr -113.83Cr
Net Debt	-2L -2L -2L -2L -3L -1.88Cr -3L -19.94L -8L -97.79L -7L -7L -3.15Cr	52.41L 47.12L 43.97L 39.86L 74.83L 50Cr 75.29L 5.28Cr 2.06Cr 26Cr 1.97Cr 1.93Cr 83Cr

Diadexus, Inc. Share Price

Stocks

DDXSQ

US25245P2056

Pharmaceuticals

Valuation: Diadexus, Inc.

Latest news: Diadexus, Inc.

Diagnostic & Testing Substances Manufacturers

Financials

Company Profile